Heart transplant pathology: the British experience

Area of Science:

• Cardiology
• Immunology
• Pathology

Background:

• Human heart transplantation is a critical treatment for end-stage heart failure.
• Histopathological analysis is vital for monitoring transplant success and complications.

Purpose of the Study:

• To present a histopathologist's perspective on human heart transplantation outcomes.
• To analyze the impact of immunosuppression and identify common reasons for transplantation and failure.

Main Methods:

• Review of 186 heart transplantations performed between January 1979 and July 1984 at two UK centers.
• Analysis of patient survival, immunosuppressive regimens (including Cyclosporin A), and causes of death.
• Monitoring of rejection via endomyocardial biopsies.

Main Results:

• 124 out of 179 patients (70%) were alive up to four years post-transplant.
• Ischaemic heart disease (63%) and congestive cardiomyopathy (35%) were the primary indications for transplantation.
• Four patients developed neoplastic lesions; seven retransplants were performed due to rejection.

Conclusions:

• Cyclosporin A-based immunosuppression demonstrated improved patient survival.
• Histopathological monitoring is crucial for managing rejection and other post-transplant complications.
• Understanding causes of death and necropsy findings aids in refining transplant protocols.